JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers

Leukemia. 2007 Nov;21(11):2386-90. doi: 10.1038/sj.leu.2404812. Epub 2007 Jun 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Female
  • Genetic Markers
  • Humans
  • Janus Kinase 2 / genetics*
  • Janus Kinase 2 / physiology*
  • Karyotyping
  • Leukemia, Myeloid, Acute / diagnosis*
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Middle Aged
  • Models, Genetic
  • Mutation*
  • Prognosis
  • Risk
  • Time Factors

Substances

  • Genetic Markers
  • Janus Kinase 2